Skip to main
AOD-9604 Compound

A research digest of AOD-9604 — the hGH C-terminal fragment 176-191, read from the published literature, antilipogenic action first, null human efficacy stated plainly.

What the compound is

What Is AOD-9604? It is a copied hormone tail.

It was made for weight loss. Mice looked promising, but the main human study failed.

The main human trial found no weight-loss help

What is AOD-9604? It is a short lab-made protein chain whose parts copy the tail of growth hormone. The compound was meant to help weight loss. The main human trial found no such help.

The copied tail changed fat use in animal cells. It slowed new fat and helped some animals burn stored fat. The copied tail didn't send the full hormone's growth message. Animal results can't prove a benefit for people.

The compound didn't raise IGF-1, the blood growth signal. It isn't an approved drug or food supplement. Sport rules also bar it. Most hopeful results still come from animals.

The AOD9604 peptide is a short protein chain

The AOD9604 peptide is a short protein chain. It copies growth hormone's tail and adds one part [3]. Two links fasten together and bend the chain. The name means "Anti-Obesity Drug 9604."

The same compound may be called AOD-9604 or AOD 9604. Some names point to the natural hormone tail. Others point to the changed lab copy. The study result matters more than the label.

Chemists also use a long formula and several file numbers. Those labels help them identify the right chain. They don't show that the compound works. You don't need them to weigh the human study.

Full growth hormone tells the growth gland to act. CJC-1295 is named only to show that this different peptide sends that message. The copied tail changed fat-making inside animal cells instead. That action did not bring human weight loss.

The AOD9604 peptide is a short protein chain

Obese mice lost weight, but people did not

Metabolic Pharmaceuticals in Australia made AOD-9604 as a weight-loss pill. The work grew from a Monash University hormone study [9]. Obese mice then lost weight and body fat. The lasting change needed the beta-3 fat-cell control [4].

Researchers later ran roughly six human trials. About 900 obese adults received AOD-9604 pills. Their side effects were much like those with placebo [5]. The main larger study found no added weight loss.

The company ended the work around 2007 [9]. The compound never won approval for any illness. Animal fat changes were real in those studies. They didn't become a proved benefit for people.

Approval and later safety remain unsettled

FDA has not approved the compound. No approved dose or FDA quality rule for makers exists [9]. Human trials don't back the fat-loss claim [10]. Most fat results came from mice, rats, or cells [7].

Human safety studies did not pass about 24 weeks. That leaves rare or later harm unknown. The world sport authority bars AOD-9604 under its hormone-drug rule [6]. The ban applies at all times.

For you, those gaps matter more than a sales claim. The effects page keeps reports apart from study findings. It also names what each kind can prove. No personal report can replace a human trial.